Literature DB >> 21565623

A novel deletion mutation in proteoglycan-4 underlies camptodactyly-arthropathy-coxa-vara-pericarditis syndrome in a consanguineous pakistani family.

Sulman Basit1, Zafar Iqbal, Masha Umicevic-Mirkov, Syed Kamran Ul-Hassan Naqvi, Marieke Coenen, Muhammad Ansar, Hans van Bokhoven, Wasim Ahmad.   

Abstract

BACKGROUND AND AIMS: Camptodactyly-arthropathy-coxa-vara-pericarditis (CACP) syndrome is an autosomal recessive condition that mostly affects joints and tendons but can also affect the pericardium, which is a surface surrounding the heart. CACP syndrome is caused by mutations in a secreted proteoglycan 4 (PRG4) gene, which expresses in skeletal as well as nonskeletal tissues. We undertook this study to genetically screen a large consanguineous Pakistani family segregating CACP in an autosomal recessive manner.
METHODS: Genome-wide homozygosity mapping of 10 members of a Pakistani family including six affected and four normal individuals was carried out using 250K SNP genotyping array. To screen for mutation in PRG4 gene, all coding exons and exon-intron junctions were sequenced using ABI prism 3730 automated DNA sequencer.
RESULTS: Genome-wide homozygosity mapping revealed a large homozygous region on chromosome 1 carried by all the affected individuals. This region contains the previously described PRG4 gene involved in CACP syndrome. Sequence analysis of PRG4 gene in affected individuals of the family presented here revealed a 2 base-pair (bp) deletion (c.2816_2817delAA) predicting a frame shift mutation (p.Lys939fsX38). To our knowledge, this is probably the first mutation identified in PRG4 gene in a Pakistani family.
CONCLUSIONS: We described a 2-bp novel deletion mutation in PRG4 gene in a Pakistani family with CACP. Our findings extend the body of evidence that only nonsense mutation in PRG4 gene triggers the phenotype.
Copyright © 2011 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565623     DOI: 10.1016/j.arcmed.2011.04.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  5 in total

1.  CACP syndrome: identification of five novel mutations and of the first case of UPD in the largest European cohort.

Authors:  Sara Ciullini Mannurita; Marina Vignoli; Lucia Bianchi; Anuela Kondi; Valeria Gerloni; Luciana Breda; Rebecca Ten Cate; Maria Alessio; Angelo Ravelli; Fernanda Falcini; Eleonora Gambineri
Journal:  Eur J Hum Genet       Date:  2013-06-12       Impact factor: 4.246

2.  Novel mutations in PRG4 gene in two Indian families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Rajashree S Nandagopalan; Shubha R Phadke; Ashwin B Dalal; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

3.  The Efficacy of Yttrium-90 Radiosynovectomy in Patients with Camptodactyly-Arthropathy-Coxa Vara-Pericarditis Syndrome.

Authors:  Sulaiman Mohammed Al-Mayouf; Nora Almutairi; Khalid Alismail
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

Review 4.  Defects in tendon, ligament, and enthesis in response to genetic alterations in key proteoglycans and glycoproteins: a review.

Authors:  Subhash C Juneja; Christian Veillette
Journal:  Arthritis       Date:  2013-11-10

5.  Genotype-phenotype investigation of 35 patients from 11 unrelated families with camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome.

Authors:  Saliha Yilmaz; Dilek Uludağ Alkaya; Özgür Kasapçopur; Kenan Barut; Ekin S Akdemir; Cemre Celen; Mark W Youngblood; Katsuhito Yasuno; Kaya Bilguvar; Murat Günel; Beyhan Tüysüz
Journal:  Mol Genet Genomic Med       Date:  2018-02-04       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.